These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment. Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550 [TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type a in the treatment of children with congenital muscular torticollis. Oleszek JL; Chang N; Apkon SD; Wilson PE Am J Phys Med Rehabil; 2005 Oct; 84(10):813-6. PubMed ID: 16205437 [TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia. Figgitt DP; Noble S Drugs; 2002; 62(4):705-22. PubMed ID: 11893235 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin injection in laryngeal dyspnea. Woisard V; Liu X; Bes MC; Simonetta-Moreau M Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):909-917. PubMed ID: 27600559 [TBL] [Abstract][Full Text] [Related]
27. Long-term botulinum toxin treatment of cervical dystonia--EMG changes in injected and noninjected muscles. Erdal J; Ostergaard L; Fuglsang-Frederiksen A; Werdelin L; Dalager T; Sjö O; Regeur L Clin Neurophysiol; 1999 Sep; 110(9):1650-4. PubMed ID: 10479034 [TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin dosing in arm muscles: contextual factors. Dressler D; Kopp B; Adib Saberi F J Neural Transm (Vienna); 2021 Mar; 128(3):315-319. PubMed ID: 33515332 [TBL] [Abstract][Full Text] [Related]
29. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Comella CL; Jankovic J; Shannon KM; Tsui J; Swenson M; Leurgans S; Fan W; Neurology; 2005 Nov; 65(9):1423-9. PubMed ID: 16275831 [TBL] [Abstract][Full Text] [Related]
30. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia. Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697 [TBL] [Abstract][Full Text] [Related]
31. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Dressler D; Benecke R Eur Neurol; 2003; 49(1):34-8. PubMed ID: 12464716 [TBL] [Abstract][Full Text] [Related]
33. Dystonia phenomenology and treatment response in migraine. Zolin A; Broner SW; Yoo A; Guan I; Lakhani S; Trabilsy M; Klebanoff L; Vo M; Sarva H Headache; 2023 Feb; 63(2):255-263. PubMed ID: 36794299 [TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin therapy in patients with oral anticoagulation: is it safe? Schrader C; Ebke M; Adib Saberi F; Dressler D J Neural Transm (Vienna); 2018 Feb; 125(2):173-176. PubMed ID: 29116410 [TBL] [Abstract][Full Text] [Related]
35. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting. Dowson AJ; Kilminster SG; Salt R Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467 [TBL] [Abstract][Full Text] [Related]